Orthopediatrics (KIDS) Free Cash Flow Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.73% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -109.40% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 133.09% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 363.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 108.16% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 29.12% |
| 10 | Orthopediatrics | 394.83 Mn | 346.02 Mn | 43.39 Mn | 39.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.79% |
| Dec 31, 2025 | -7.49% |
| Sep 30, 2025 | 70.67% |
| Jun 30, 2025 | -8.85% |
| Mar 31, 2025 | 36.25% |
| Dec 31, 2024 | 112.76% |
| Sep 30, 2024 | -4.59% |
| Jun 30, 2024 | -27.81% |
| Mar 31, 2024 | -15.34% |
| Dec 31, 2023 | -31.33% |
| Sep 30, 2023 | -55.98% |
| Jun 30, 2023 | 25.61% |
| Mar 31, 2023 | -35.82% |
| Dec 31, 2022 | 351.32% |
| Sep 30, 2022 | -143.84% |
| Jun 30, 2022 | -25.58% |
| Mar 31, 2022 | -79.97% |
| Dec 31, 2021 | 31.88% |
| Sep 30, 2021 | 40.84% |
| Jun 30, 2021 | -19.46% |
| Mar 31, 2021 | 57.25% |
| Dec 31, 2020 | 47.74% |
| Sep 30, 2020 | -102.12% |
| Jun 30, 2020 | 14.64% |
| Mar 31, 2020 | -29.35% |
| Dec 31, 2019 | -201.95% |
| Sep 30, 2019 | -5.37% |
| Jun 30, 2019 | -30.59% |
| Mar 31, 2019 | -8.07% |
| Dec 31, 2018 | 41.72% |
| Sep 30, 2018 | -204.05% |
| Jun 30, 2018 | -39.98% |
| Mar 31, 2018 | -483.69% |
| Dec 31, 2017 | -1,006.52% |